The global OTC Eye Drops and Lubricants Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.This report mainly studies OTC eye drops and lubricants drugs market.

From a downstream perspective, Retail Pharmacies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

OTC Eye Drops and Lubricants Drugs leading manufacturers including Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), etc., dominate supply; the top five capture approximately % of global revenue, with Alcon leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global OTC Eye Drops and Lubricants Drugs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of OTC Eye Drops and Lubricants Drugs Market Report

Report Metric	Details
Report Name	OTC Eye Drops and Lubricants Drugs Market
Segment by Type	Contact Lenses Eyedrop Allergy Eyedrop Dry Eye Drop Others
Segment by Application	Retail Pharmacies Optical Channel Online Pharmacies Hospital Pharmacies
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhengshiming
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the OTC Eye Drops and Lubricants Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the OTC Eye Drops and Lubricants Drugs Market report?

Ans: The main players in the OTC Eye Drops and Lubricants Drugs Market are Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhengshiming

What are the Application segmentation covered in the OTC Eye Drops and Lubricants Drugs Market report?

Ans: The Applications covered in the OTC Eye Drops and Lubricants Drugs Market report are Retail Pharmacies, Optical Channel, Online Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the OTC Eye Drops and Lubricants Drugs Market report?

Ans: The Types covered in the OTC Eye Drops and Lubricants Drugs Market report are Contact Lenses Eyedrop, Allergy Eyedrop, Dry Eye Drop, Others

1 Study Coverage

1.1 Introduction to OTC Eye Drops and Lubricants Drugs: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global OTC Eye Drops and Lubricants Drugs Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Contact Lenses Eyedrop

1.2.3 Allergy Eyedrop

1.2.4 Dry Eye Drop

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global OTC Eye Drops and Lubricants Drugs Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Retail Pharmacies

1.3.3 Optical Channel

1.3.4 Online Pharmacies

1.3.5 Hospital Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global OTC Eye Drops and Lubricants Drugs Revenue Estimates and Forecasts 2020-2031

2.2 Global OTC Eye Drops and Lubricants Drugs Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global OTC Eye Drops and Lubricants Drugs Sales Estimates and Forecasts 2020-2031

2.4 Global OTC Eye Drops and Lubricants Drugs Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global OTC Eye Drops and Lubricants Drugs Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global OTC Eye Drops and Lubricants Drugs Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Contact Lenses Eyedrop Market Size by Manufacturers

3.5.2 Allergy Eyedrop Market Size by Manufacturers

3.5.3 Dry Eye Drop Market Size by Manufacturers

3.5.4 Others Market Size by Manufacturers

3.6 Global OTC Eye Drops and Lubricants Drugs Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global OTC Eye Drops and Lubricants Drugs Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global OTC Eye Drops and Lubricants Drugs Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global OTC Eye Drops and Lubricants Drugs Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global OTC Eye Drops and Lubricants Drugs Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America OTC Eye Drops and Lubricants Drugs Sales and Revenue by Type (2020-2031)

6.4 North America OTC Eye Drops and Lubricants Drugs Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America OTC Eye Drops and Lubricants Drugs Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe OTC Eye Drops and Lubricants Drugs Sales and Revenue by Type (2020-2031)

7.4 Europe OTC Eye Drops and Lubricants Drugs Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe OTC Eye Drops and Lubricants Drugs Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific OTC Eye Drops and Lubricants Drugs Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America OTC Eye Drops and Lubricants Drugs Sales and Revenue by Type (2020-2031)

9.4 Central and South America OTC Eye Drops and Lubricants Drugs Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America OTC Eye Drops and Lubricants Drugs Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa OTC Eye Drops and Lubricants Drugs Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa OTC Eye Drops and Lubricants Drugs Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa OTC Eye Drops and Lubricants Drugs Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Alcon

11.1.1 Alcon Corporation Information

11.1.2 Alcon Business Overview

11.1.3 Alcon OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.1.4 Alcon OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Alcon OTC Eye Drops and Lubricants Drugs Sales by Product in 2024

11.1.6 Alcon OTC Eye Drops and Lubricants Drugs Sales by Application in 2024

11.1.7 Alcon OTC Eye Drops and Lubricants Drugs Sales by Geographic Area in 2024

11.1.8 Alcon OTC Eye Drops and Lubricants Drugs SWOT Analysis

11.1.9 Alcon Recent Developments

11.2 AbbVie

11.2.1 AbbVie Corporation Information

11.2.2 AbbVie Business Overview

11.2.3 AbbVie OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.2.4 AbbVie OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 AbbVie OTC Eye Drops and Lubricants Drugs Sales by Product in 2024

11.2.6 AbbVie OTC Eye Drops and Lubricants Drugs Sales by Application in 2024

11.2.7 AbbVie OTC Eye Drops and Lubricants Drugs Sales by Geographic Area in 2024

11.2.8 AbbVie OTC Eye Drops and Lubricants Drugs SWOT Analysis

11.2.9 AbbVie Recent Developments

11.3 Thea pharmaceuticals

11.3.1 Thea pharmaceuticals Corporation Information

11.3.2 Thea pharmaceuticals Business Overview

11.3.3 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.3.4 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs Sales by Product in 2024

11.3.6 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs Sales by Application in 2024

11.3.7 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs Sales by Geographic Area in 2024

11.3.8 Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs SWOT Analysis

11.3.9 Thea pharmaceuticals Recent Developments

11.4 Bausch Health

11.4.1 Bausch Health Corporation Information

11.4.2 Bausch Health Business Overview

11.4.3 Bausch Health OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.4.4 Bausch Health OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Bausch Health OTC Eye Drops and Lubricants Drugs Sales by Product in 2024

11.4.6 Bausch Health OTC Eye Drops and Lubricants Drugs Sales by Application in 2024

11.4.7 Bausch Health OTC Eye Drops and Lubricants Drugs Sales by Geographic Area in 2024

11.4.8 Bausch Health OTC Eye Drops and Lubricants Drugs SWOT Analysis

11.4.9 Bausch Health Recent Developments

11.5 URSAPHARM

11.5.1 URSAPHARM Corporation Information

11.5.2 URSAPHARM Business Overview

11.5.3 URSAPHARM OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.5.4 URSAPHARM OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 URSAPHARM OTC Eye Drops and Lubricants Drugs Sales by Product in 2024

11.5.6 URSAPHARM OTC Eye Drops and Lubricants Drugs Sales by Application in 2024

11.5.7 URSAPHARM OTC Eye Drops and Lubricants Drugs Sales by Geographic Area in 2024

11.5.8 URSAPHARM OTC Eye Drops and Lubricants Drugs SWOT Analysis

11.5.9 URSAPHARM Recent Developments

11.6 OmniVision Pharma

11.6.1 OmniVision Pharma Corporation Information

11.6.2 OmniVision Pharma Business Overview

11.6.3 OmniVision Pharma OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.6.4 OmniVision Pharma OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 OmniVision Pharma Recent Developments

11.7 Rohto

11.7.1 Rohto Corporation Information

11.7.2 Rohto Business Overview

11.7.3 Rohto OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.7.4 Rohto OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Rohto Recent Developments

11.8 Prestige Consumer Healthcare

11.8.1 Prestige Consumer Healthcare Corporation Information

11.8.2 Prestige Consumer Healthcare Business Overview

11.8.3 Prestige Consumer Healthcare OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.8.4 Prestige Consumer Healthcare OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Prestige Consumer Healthcare Recent Developments

11.9 LION

11.9.1 LION Corporation Information

11.9.2 LION Business Overview

11.9.3 LION OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.9.4 LION OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 LION Recent Developments

11.10 Kenvue (VISINE)

11.10.1 Kenvue (VISINE) Corporation Information

11.10.2 Kenvue (VISINE) Business Overview

11.10.3 Kenvue (VISINE) OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.10.4 Kenvue (VISINE) OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Kenvue (VISINE) Recent Developments

11.11 Santen Pharma

11.11.1 Santen Pharma Corporation Information

11.11.2 Santen Pharma Business Overview

11.11.3 Santen Pharma OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.11.4 Santen Pharma OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Santen Pharma Recent Developments

11.12 CooperVision

11.12.1 CooperVision Corporation Information

11.12.2 CooperVision Business Overview

11.12.3 CooperVision OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.12.4 CooperVision OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 CooperVision Recent Developments

11.13 Zhengshiming

11.13.1 Zhengshiming Corporation Information

11.13.2 Zhengshiming Business Overview

11.13.3 Zhengshiming OTC Eye Drops and Lubricants Drugs Product Models, Descriptions and Specifications

11.13.4 Zhengshiming OTC Eye Drops and Lubricants Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Zhengshiming Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 OTC Eye Drops and Lubricants Drugs Industry Chain

12.2 OTC Eye Drops and Lubricants Drugs Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 OTC Eye Drops and Lubricants Drugs Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 OTC Eye Drops and Lubricants Drugs Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 OTC Eye Drops and Lubricants Drugs Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global OTC Eye Drops and Lubricants Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Prestige Consumer Healthcare

List of Tables

Table 1. Global OTC Eye Drops and Lubricants Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global OTC Eye Drops and Lubricants Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global OTC Eye Drops and Lubricants Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global OTC Eye Drops and Lubricants Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global OTC Eye Drops and Lubricants Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global OTC Eye Drops and Lubricants Drugs Sales by Region (2020-2025) & (K Units)

Table 8. Global OTC Eye Drops and Lubricants Drugs Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global OTC Eye Drops and Lubricants Drugs Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global OTC Eye Drops and Lubricants Drugs Sales Share by Manufacturers (2020-2025)

Table 12. Global OTC Eye Drops and Lubricants Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global OTC Eye Drops and Lubricants Drugs Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global OTC Eye Drops and Lubricants Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Eye Drops and Lubricants Drugs as of 2024)

Table 16. Global OTC Eye Drops and Lubricants Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global OTC Eye Drops and Lubricants Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers OTC Eye Drops and Lubricants Drugs Manufacturing Base and Headquarters

Table 19. Global OTC Eye Drops and Lubricants Drugs Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global OTC Eye Drops and Lubricants Drugs Sales by Type (2020-2025) & (K Units)

Table 23. Global OTC Eye Drops and Lubricants Drugs Sales by Type (2026-2031) & (K Units)

Table 24. Global OTC Eye Drops and Lubricants Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global OTC Eye Drops and Lubricants Drugs Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global OTC Eye Drops and Lubricants Drugs ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global OTC Eye Drops and Lubricants Drugs Sales by Application (2020-2025) & (K Units)

Table 29. Global OTC Eye Drops and Lubricants Drugs Sales by Application (2026-2031) & (K Units)

Table 30. OTC Eye Drops and Lubricants Drugs High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global OTC Eye Drops and Lubricants Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global OTC Eye Drops and Lubricants Drugs Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global OTC Eye Drops and Lubricants Drugs ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America OTC Eye Drops and Lubricants Drugs Growth Accelerators and Market Barriers

Table 37. North America OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America OTC Eye Drops and Lubricants Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe OTC Eye Drops and Lubricants Drugs Growth Accelerators and Market Barriers

Table 40. Europe OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe OTC Eye Drops and Lubricants Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific OTC Eye Drops and Lubricants Drugs Growth Accelerators and Market Barriers

Table 45. Southeast Asia OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America OTC Eye Drops and Lubricants Drugs Investment Opportunities and Key Challenges

Table 47. Central and South America OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa OTC Eye Drops and Lubricants Drugs Investment Opportunities and Key Challenges

Table 49. Middle East and Africa OTC Eye Drops and Lubricants Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Alcon Corporation Information

Table 51. Alcon Description and Major Businesses

Table 52. Alcon Product Models, Descriptions and Specifications

Table 53. Alcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Alcon Sales Value Proportion by Product in 2024

Table 55. Alcon Sales Value Proportion by Application in 2024

Table 56. Alcon Sales Value Proportion by Geographic Area in 2024

Table 57. Alcon OTC Eye Drops and Lubricants Drugs SWOT Analysis

Table 58. Alcon Recent Developments

Table 59. AbbVie Corporation Information

Table 60. AbbVie Description and Major Businesses

Table 61. AbbVie Product Models, Descriptions and Specifications

Table 62. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. AbbVie Sales Value Proportion by Product in 2024

Table 64. AbbVie Sales Value Proportion by Application in 2024

Table 65. AbbVie Sales Value Proportion by Geographic Area in 2024

Table 66. AbbVie OTC Eye Drops and Lubricants Drugs SWOT Analysis

Table 67. AbbVie Recent Developments

Table 68. Thea pharmaceuticals Corporation Information

Table 69. Thea pharmaceuticals Description and Major Businesses

Table 70. Thea pharmaceuticals Product Models, Descriptions and Specifications

Table 71. Thea pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Thea pharmaceuticals Sales Value Proportion by Product in 2024

Table 73. Thea pharmaceuticals Sales Value Proportion by Application in 2024

Table 74. Thea pharmaceuticals Sales Value Proportion by Geographic Area in 2024

Table 75. Thea pharmaceuticals OTC Eye Drops and Lubricants Drugs SWOT Analysis

Table 76. Thea pharmaceuticals Recent Developments

Table 77. Bausch Health Corporation Information

Table 78. Bausch Health Description and Major Businesses

Table 79. Bausch Health Product Models, Descriptions and Specifications

Table 80. Bausch Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Bausch Health Sales Value Proportion by Product in 2024

Table 82. Bausch Health Sales Value Proportion by Application in 2024

Table 83. Bausch Health Sales Value Proportion by Geographic Area in 2024

Table 84. Bausch Health OTC Eye Drops and Lubricants Drugs SWOT Analysis

Table 85. Bausch Health Recent Developments

Table 86. URSAPHARM Corporation Information

Table 87. URSAPHARM Description and Major Businesses

Table 88. URSAPHARM Product Models, Descriptions and Specifications

Table 89. URSAPHARM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. URSAPHARM Sales Value Proportion by Product in 2024

Table 91. URSAPHARM Sales Value Proportion by Application in 2024

Table 92. URSAPHARM Sales Value Proportion by Geographic Area in 2024

Table 93. URSAPHARM OTC Eye Drops and Lubricants Drugs SWOT Analysis

Table 94. URSAPHARM Recent Developments

Table 95. OmniVision Pharma Corporation Information

Table 96. OmniVision Pharma Description and Major Businesses

Table 97. OmniVision Pharma Product Models, Descriptions and Specifications

Table 98. OmniVision Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. OmniVision Pharma Recent Developments

Table 100. Rohto Corporation Information

Table 101. Rohto Description and Major Businesses

Table 102. Rohto Product Models, Descriptions and Specifications

Table 103. Rohto Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Rohto Recent Developments

Table 105. Prestige Consumer Healthcare Corporation Information

Table 106. Prestige Consumer Healthcare Description and Major Businesses

Table 107. Prestige Consumer Healthcare Product Models, Descriptions and Specifications

Table 108. Prestige Consumer Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Prestige Consumer Healthcare Recent Developments

Table 110. LION Corporation Information

Table 111. LION Description and Major Businesses

Table 112. LION Product Models, Descriptions and Specifications

Table 113. LION Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. LION Recent Developments

Table 115. Kenvue (VISINE) Corporation Information

Table 116. Kenvue (VISINE) Description and Major Businesses

Table 117. Kenvue (VISINE) Product Models, Descriptions and Specifications

Table 118. Kenvue (VISINE) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Kenvue (VISINE) Recent Developments

Table 120. Santen Pharma Corporation Information

Table 121. Santen Pharma Description and Major Businesses

Table 122. Santen Pharma Product Models, Descriptions and Specifications

Table 123. Santen Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Santen Pharma Recent Developments

Table 125. CooperVision Corporation Information

Table 126. CooperVision Description and Major Businesses

Table 127. CooperVision Product Models, Descriptions and Specifications

Table 128. CooperVision Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. CooperVision Recent Developments

Table 130. Zhengshiming Corporation Information

Table 131. Zhengshiming Description and Major Businesses

Table 132. Zhengshiming Product Models, Descriptions and Specifications

Table 133. Zhengshiming Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Zhengshiming Recent Developments

Table 135. Key Raw Materials Distribution

Table 136. Raw Materials Key Suppliers

Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 138. Milestones in Production Technology Evolution

Table 139. Distributors List

Table 140. Market Trends and Market Evolution

Table 141. Market Drivers and Opportunities

Table 142. Market Challenges, Risks, and Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. OTC Eye Drops and Lubricants Drugs Product Picture

Figure 2. Global OTC Eye Drops and Lubricants Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Contact Lenses Eyedrop Product Picture

Figure 4. Allergy Eyedrop Product Picture

Figure 5. Dry Eye Drop Product Picture

Figure 6. Others Product Picture

Figure 7. Global OTC Eye Drops and Lubricants Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Retail Pharmacies

Figure 9. Optical Channel

Figure 10. Online Pharmacies

Figure 11. Hospital Pharmacies

Figure 12. OTC Eye Drops and Lubricants Drugs Report Years Considered

Figure 13. Global OTC Eye Drops and Lubricants Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 15. Global OTC Eye Drops and Lubricants Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global OTC Eye Drops and Lubricants Drugs Revenue Market Share by Region (2020-2031)

Figure 17. Global OTC Eye Drops and Lubricants Drugs Sales (2020-2031) & (K Units)

Figure 18. Global OTC Eye Drops and Lubricants Drugs Sales (CAGR) by Region (2020-2031) (K Units)

Figure 19. Global OTC Eye Drops and Lubricants Drugs Sales Market Share by Region (2020-2031)

Figure 20. Top 5 and Top 10 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Volume Market Share in 2024

Figure 21. Global OTC Eye Drops and Lubricants Drugs Revenue Market Share Ranking (2024)

Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 23. Contact Lenses Eyedrop Revenue Market Share by Manufacturer in 2024

Figure 24. Allergy Eyedrop Revenue Market Share by Manufacturer in 2024

Figure 25. Dry Eye Drop Revenue Market Share by Manufacturer in 2024

Figure 26. Others Revenue Market Share by Manufacturer in 2024

Figure 27. Global OTC Eye Drops and Lubricants Drugs Sales Market Share by Type (2020-2031)

Figure 28. Global OTC Eye Drops and Lubricants Drugs Revenue Market Share by Type (2020-2031)

Figure 29. Global OTC Eye Drops and Lubricants Drugs Sales Market Share by Application (2020-2031)

Figure 30. Global OTC Eye Drops and Lubricants Drugs Revenue Market Share by Application (2020-2031)

Figure 31. North America OTC Eye Drops and Lubricants Drugs Sales YoY (2020-2031) & (K Units)

Figure 32. North America OTC Eye Drops and Lubricants Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 33. North America Top 5 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) in 2024

Figure 34. North America OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Type (2020- 2031)

Figure 35. North America OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 36. North America OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 37. North America OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 38. US OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 39. Canada OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 40. Mexico OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 41. Europe OTC Eye Drops and Lubricants Drugs Sales YoY (2020-2031) & (K Units)

Figure 42. Europe OTC Eye Drops and Lubricants Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 43. Europe Top 5 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) in 2024

Figure 44. Europe OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Type (2020-2031)

Figure 45. Europe OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 46. Europe OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 47. Europe OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 48. Germany OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 49. France OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 50. U.K. OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 51. Italy OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 52. Russia OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 53. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales YoY (2020-2031) & (K Units)

Figure 54. Asia-Pacific OTC Eye Drops and Lubricants Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Asia-Pacific Top 8 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) in 2024

Figure 56. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Type (2020- 2031)

Figure 57. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 58. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 59. Asia-Pacific OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 60. Indonesia OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 61. Japan OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 62. South Korea OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 63. China Taiwan OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 64. India OTC Eye Drops and Lubricants Drugs Revenue (2020-2031) & (US$ Million)

Figure 65. Central and South America OTC Eye Drops and Lubricants Drugs Sales YoY (2020-2031) & (K Units)

Figure 66. Central and South America OTC Eye Drops and Lubricants Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 67. Central and South America Top 5 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) in 2024

Figure 68. Central and South America OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Type (2021-2031)

Figure 69. Central and South America OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 70. Central and South America OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 71. Central and South America OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 72. Brazil OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 73. Argentina OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 74. Middle East, and Africa OTC Eye Drops and Lubricants Drugs Sales YoY (2020-2031) & (K Units)

Figure 75. Middle East and Africa OTC Eye Drops and Lubricants Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 76. Middle East and Africa Top 5 Manufacturers OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) in 2024

Figure 77. Middle East and Africa OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Type (2021-2031)

Figure 78. South America OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 79. Middle East and Africa OTC Eye Drops and Lubricants Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 80. Middle East and Africa OTC Eye Drops and Lubricants Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 81. GCC Countries OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 82. Turkey OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 83. Egypt OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 84. South Africa OTC Eye Drops and Lubricants Drugs Revenue (2020-2025) & (US$ Million)

Figure 85. OTC Eye Drops and Lubricants Drugs Industry Chain Mapping

Figure 86. Regional OTC Eye Drops and Lubricants Drugs Manufacturing Base Distribution (%)

Figure 87. Global OTC Eye Drops and Lubricants Drugs Production Market Share by Region (2020-2031)

Figure 88. OTC Eye Drops and Lubricants Drugs Production Process

Figure 89. Regional OTC Eye Drops and Lubricants Drugs Production Cost Structure

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions